Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea · Delayed Price · Currency is KRW 15,320
+80 (0.52%)
Sep 22, 2026, 3:30 PM KST
Kolon TissueGene Market Cap
Kolon TissueGene has a market cap or net worth of 1.29 trillion as of September 21, 2026. Its market cap has decreased by -65.41% in one year.
Market Cap
1.29T
Enterprise Value
1.26T
Revenue
4.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
15,320.00
ChartMarket Cap Chart
Since November 6, 2017, Kolon TissueGene's market cap has decreased from 2.58T to 1.29T, a decrease of -49.77%. That is a compound annual growth rate of -7.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 1.29T | -80.45% |
| Dec 30, 2025 | 6.62T | 258.54% |
| Dec 30, 2024 | 1.85T | 181.73% |
| Dec 28, 2023 | 655.80B | 7.08% |
| Dec 29, 2022 | 612.43B | -76.74% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SK bioscience | 2.74T |
| OliX Pharmaceuticals | 2.54T |
| Voronoi | 2.38T |
| Hugel | 2.31T |
| D&D Pharmatech | 2.08T |
| Orum Therapeutics | 812.31B |
| Pharmicell | 751.85B |
| Chabiotech | 740.02B |